An EU pilot program on monitoring drug safety may be soon be terminated, after running for over six years and generating, according to the industry, little additional value in terms of improving patient safety.
The European Commission is working on a legislative amendment that is expected to put an end to the EU signal detection pilot, under which sponsors of certain medicines (ie, those...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?